DMRADamora Therapeutics, Inc.

$30.44

Who owns DMRA

65 institutions reported holding DMRA for 2026Q1, together 163% of the company, more than the 18 a quarter earlier.

65

Institutions reporting a position · as of 2026Q1 · up from 18 the quarter before

Shares held by institutions
56.0M

Shares held by institutions · 163% of the company · long US equity positions only, as reported on Form 13F

Reported value
$1.45B

Reported value · at 2026-03-31 prices, not today's

Opened vs closed
48 / 3

Opened vs closed · new positions against positions exited in the latest quarter

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
7
New positions
48
Positions exited
3
Added to
14
Reduced
0
Institutional ownership by quarter, 2024Q3 to 2026Q1
QuarterFilersSharesReported value
2026Q16556.0M$1.45B
2025Q4181.1M$65M
2025Q3120.2M$633K
2025Q290.1M$451K
2025Q1110.1M$442K
2024Q4100.1M$661K
2024Q3100.1M$1.6M
Largest reported holders, 2026Q1
HolderShares% of companyValue
FMR LLC9.0Mn/a$234M
Fairmount Funds Management LLC8.7Mn/a$226M
Avoro Capital Advisors LLC3.8Mn/a$98M
Venrock Adviser, LLC3.6Mn/a$93M
FCPM III SERVICES B.V.2.4Mn/a$63M
RA CAPITAL MANAGEMENT, L.P.2.4Mn/a$62M
HENDERSON GROUP PLC2.4Mn/a$61M
VIKING GLOBAL INVESTORS LP2.3Mn/a$60M
Bellevue Group AG2.3Mn/a$60M
Remedium Capital Partners, LLC2.0Mn/a$53M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…